Overview
EVA discovery platform integrating machine learning, robotic automation, and synthetic biology to design and optimize multispecific therapeutic antibodies; internal pipeline including LGTX-101 and pharma partnership programs.
Product and company
LabGenius — Biotechnology is a verified product offering linked to the Brel Digital company profile for LabGenius.
Use cases
EVA discovery platform integrating machine learning, robotic automation, and synthetic biology to design and optimize multispecific therapeutic antibodies; internal pipeline including LGTX-101 and pharma partnership programs.
Target customer
Pharmaceutical and biotech partners seeking AI-designed multispecific antibodies, and investors evaluating ML-driven drug discovery with internal clinical-stage assets.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Machine Learning, Predictive Analytics.
Sources and references
- Official product / company source: https://labgeniustx.com/press-release-lgchem/
- Supporting source: https://labgeniustx.com/team/
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- EVA discovery platform integrating machine learning, robotic automation, and synthetic biology to design and optimize mul
- LGTX-101
- pharma partnership programs
Extracted from the linked company product description already verified on Brel. No capabilities were invented.